- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai. Lupin develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the U.S., India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
Lupin's subsidiary VISUfarma inked an exclusive deal with Visus Therapeutics to commercialize YUVEZZI™ for presbyopia in Europe. This strengthens Lupin’s ophthalmology portfolio and expands its specialty business, targeting long-term growth. The deal involves up to €7.5 Cr plus royalties.